Diabetic ketoacidosis in an HIV-infected patient undergoing antiretroviral therapy

Keyphrases

• Antiretroviral Therapy 100%
• Diabetic Ketoacidosis 100%
• HIV-infected Patients 100%
• Insulin Resistance 66%
• Protease Inhibitors 66%
• Hyperglycemia 33%
• β-cell Function 33%
• Highly Active Antiretroviral Therapy (HAART) 33%
• Morphological Changes 33%
• Metabolic Alterations 33%
• HIV-associated Lipodystrophy Syndrome 33%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Antiretroviral Therapy 100%
• Diabetic Ketoacidosis 100%
• Insulin Resistance 66%
• Proteinase Inhibitor 66%
• Morphology 33%
• Cell Function 33%
• Beta Cell 33%
• Hyperglycemia 33%
• Highly Active Antiretroviral Therapy 33%
• HIV-associated Lipodystrophy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Diabetic Ketoacidosis 100%
• Insulin Resistance 66%
• Proteinase Inhibitor 66%
• Hyperglycemia 33%
• HIV Associated Lipodystrophy 33%